A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients with diabetes who took PPARy-targeting drugs stayed cancer-free during follow-up. The drug, pioglitazone, appears to rewire cancer cell metabolism and suppress growth. Promising Drug Discovery in Prostate Cancer In a discovery that could open new doors for [...]from SciTechDaily https://ift.tt/A3H0KZd
Post a Comment
0 Comments